Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-05 4:30 pm Sale | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 0 0.000% | -65,679,781 (Position Closed) | View |
| 2023-12-08 5:00 pm Unchanged | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 65,679,781 36.400% | 0 (Unchanged) | View |
| 2023-10-18 4:32 pm Purchase | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 65,679,781 36.500% | 5,047,425 (+8.32%) | View |
| 2022-08-18 4:30 pm Unchanged | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,632,356 38.900% | 0 (Unchanged) | View |
| 2022-03-03 4:52 pm Unchanged | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,632,356 41.000% | 0 (Unchanged) | View |
| 2021-07-09 5:05 pm Purchase | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,632,356 42.900% | 332,293 (+0.55%) | View |
| 2020-11-04 4:45 pm Purchase | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,300,063 47.400% | 60,300,063 (New Position) | View |